FOCIS 2019 Poster Resources

Federation of Clinical Immunology Societies (FOCIS) Annual Meeting

Boston, MA | June 18- 21, 2019

Immune cells are a key element in the research and development of therapeutics presented in the Charles River Posters at the Federation of Clinical Immunology Societies (FOCIS) Annual Meeting.

Charles River was proud to contribute to the scientific program of the 2019 FOCIS Annual Meeting with 13 poster presentations covering a variety of research topics. We invite you to review and download a copy of the posters listed below.

Scientific Poster Presentations

A Translational Platform to Support and Advance Immuno-Oncology Drug Discovery | Jeroen De Groot, PhD

Analysis of Molecular and Cellular Responses Associated with Immune Checkpoint Inhibition in the MC38 Colon Carcinoma Model | David Harris, PhD

Building a Translational Pathway Using Human Myeloid Cell Assays to Enable Development of Cancer Immune Therapies | Louise Brackenbury, PhD

Building a Translational Pathway Using Pharmacodynamic Models to Enable the Development of Cancer Immune Therapies | Rhiannon Jenkinson, PhD

Deciphering the Role of the Tumor Infiltrating Lymphocytes in Anti-Angiogenic Therapy Using a Humanized PDX In Vivo Platform | Julia Schueler, PhD

Development of In Vitro Assays for the Assessment of Potential Drugs Regulating the Migration of Blood-Derived Human Monocytes or Neutrophils | Lisa Scandiuzzi, PhD

Evaluation of Different Lactobacillus Strains on the Treatment of Inflammatory Bowel Disease in a Murine Model | Rana Samadfam, PhD

Inclusion of Exploratory PD Biomarkers in First-in-human Clinical Trials Adds Value by Providing Information to Confirm the Mode of Action of a Candidate Therapeutic | Rhiannon Jenkinson, PhD

LPS-induced Neuroinflammation Assay Combination for Development of New Treatment Strategies | Gunnar Flik, PhD

Modelling Inflammatory Bowel Disease using a Translational Assay Platform | Louise Brackenbury, PhD

Profiling of 1,600 Novel Natural Product-based Compounds in Human Primary Cell-based Phenotypic Assays | Jamil Aarbiou, PhD

Th17-derived Cytokines Might be Involved in the Allergic Contact Dermatitis Induced by Poison Ivy Active Ingredient, Urushiol | Rana Samadfam, PhD

Two In Vitro Assays for Evaluating the Potency and Efficacy of Prospective Drugs in Multiple Diseases Involving Both Classically and Alternative Activated Macrophages | Sanne Demandt, PhD